Physician profile
Nora Vanegas Arroyave
NPI 1790009686
$82,202.42
in general payments reported to CMS, 2019-2025
18 companies · $5,260 in 2025
The $5,260 reported for 2025 was more than what 84% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $25K · 2021: $8,781 · 2022: $1,514 · 2023: $704 · 2024: $1,385 · 2025: $5,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,950 · Food and Beverage: $2,401 · Travel and Lodging: $1,916 · Education: $81.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,950.00 |
| Food and Beverage | $2,401.35 |
| Travel and Lodging | $1,916.14 |
| Education | $81.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $64,634.36 | 2019-2024 | Ingrezza |
| Travere Therapeutics, INC. | $5,000.00 | 2019 | |
| Medtronic, INC. | $3,779.52 | 2021-2025 | Percept Pc Brainsense, Activa Pc |
| Abbott Laboratories | $3,460.02 | 2019-2025 | Proclaim, Infinity |
| Boston Scientific Corporation | $1,537.62 | 2019-2024 | Bionic Navigator |
| Acorda Therapeutics, INC | $1,403.15 | 2019-2024 | Inbrija |
| Saluda Medical Americas, INC. | $529.78 | 2024 | Evoke |
| Merz Pharmaceuticals, LLC | $422.80 | 2021-2023 | Xeomin |
| Insightec,INC | $302.07 | 2022-2023 | Exablate |
| Abbvie INC. | $252.87 | 2019-2024 | Duopa |
| Acadia Pharmaceuticals INC | $250.96 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $209.56 | 2021-2025 | |
| Mdd US Operations, LLC | $149.11 | 2019 | |
| Medtronic USA, INC. | $98.90 | 2019 | |
| Allergan, INC. | $62.80 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $46.79 | 2020 | |
| Argenx US, INC. | $31.11 | 2022 | |
| Biogen, INC. | $31.00 | 2023 | Skyclarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Vanegas Arroyave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.